IP Library › Patent Application 11922838
Patent Application
App. No. 11/922,838

Use of Activators of Soluble Guanylate Cyclase for Treating Reperfusion Damage

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/922,838
Abstract

The present invention relates to the use of compounds for manufacturing a pharmaceutical product/medicament for the prophylaxis and/or treatment of reperfusion damage.

Claims (8)

1 . A method for the prophylaxis and/or treatment of reperfusion damage comprising administering a medicament comprising an effective amount of a compound of the formulae (I-VI)

or a salt, hydrate, or hydrate of a salt thereof.

2 . The method as claimed in claim 1 , in which the medicament is used for an oral dosage form.

3 . The method as claimed in claim 1 , in which the medicament is given intravenously.

4 . The method as claimed in claim 1 , in which the medicament is preventive.

5 . The method as claimed in claim 1 , in which the medicament is used for the prophylaxis and/or treatment of reperfusion damage.

6 . A pharmaceutical composition for the treatment of reperfusion damage, which comprises at least one substance as described in a claim 1 .

7 . The pharmaceutical composition as claimed in claim 6 , which additionally comprises a medicament selected from the group of inhibitors of phosphodiesterases, thrombolytics and adenosine agonists.

Assignments (2)
MERGER Recorded Feb 18, 2011
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025837/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2009
From: KRAHN, THOMAS; STASCH, JOHANNES-PETER; WEIMANN, GERRIT; THIELEMANN, WOLFGANG
To: BAYER HEALTHCARE AG
Reel/Frame 023410/0164 →